Table 4.
Complications and In-Hospital Outcomes.a
| Characteristics | RC 2-3: Claudicants (214 patients, 251 lesions) | RC 4-5: CLTI (233 patients, 289 lesions) | RC 6: CLTI (56 patients, 77 lesions) | p |
|---|---|---|---|---|
| Procedure successb per patient | 170/205 (82.9) | 169/213 (79.3) | 38/50 (76.0) | 0.434 |
| Lesion successb | 201/240 (83.8) | 219/271 (80.8) | 56/71 (78.9) | 0.551 |
| Severe angiographic complications (per lesion) | 23/248 (9.3) | 32/287 (11.1) | 10/74 (13.5) | 0.669 |
| Severe dissection (types C-F) | 4/251 (1.6) | 7/289 (2.4) | 2/77 (2.6) | 0.741 |
| Perforation | 3/251 (1.2) | 6/289 (2.1) | 1/77 (1.3) | 0.707 |
| Distal embolization | 16/247 (6.5) | 16/287 (5.6) | 6/74 (8.1) | 0.487 |
| Abrupt closure | 1/251 (0.4) | 7/289 (2.4) | 1/77 (1.3) | 0.115 |
| MAE | 0/211 | 0/227 | 3/55 (5.5) | 0.001 |
| Death | 0/211 | 0/227 | 2/55 (3.6) | 0.015 |
| Major amputation | 0/211 | 0/227 | 1/55 (1.8) | 0.109 |
| TVR | 0/211 | 0/227 | 0/55 |
Abbreviations: MAE, major adverse events; RC, Rutherford category; TVR, target vessel revascularization.
a
Data are given as the number/sample (percentage). Sample sizes may differ from the group number owing to missing data.
b
Success defined as <50% residual stenosis, without significant angiographic complications.